DPC4 Expression in the Small Intestinal Adenocarcinomas
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Small intestinal adenocarcinomas (SACs) are rare malignancies of the alimentary tract with uncertain carcinogenesis. Methods: We investigated the expression of deleted in pancreatic cancer 4 (DPC4) in 188 cases of surgically resected SACs, using tissue microarray technology. Results: Twenty-four of the 188 tumors showed complete loss of Smad4/DPC4 expression in cytoplasm (score, 0; 12.8%). Eighty-four and 31 cases were moderately and strongly positive, respectively (score, 2 and 3; 44.7% and 16.5%, respectively) and 49 cases were focally or weakly stained (score, 1; 29.1%). Immunohistochemistry analysis showed that the expression of Smad4/DPC4 was related to an increased risk of lymphatic invasion but not to other clinicopathological features of the tumors (tumor location, differentiation, growth pattern, T stage, direct invasion, vascular invasion, and nodal metastasis). There was no significant association between Smad4/DPC4 expression and patient survival. Conclusions: The present research is the first study to evaluate Smad4/DPC4 expression in a large sample of SACs with clinicopathologic correlation. Future studies should focus on the immunohistochemical and molecular characteristics of SACs to clarify their tumorigenesis.
Abstract
Background: Small intestinal adenocarcinomas (SACs) are rare malignancies of the alimentary tract with uncertain carcinogenesis. Methods: We investigated the expression of deleted in pancreatic cancer 4 (DPC4) in 188 cases of surgically resected SACs, using tissue microarray technology. Results: Twenty-four of the 188 tumors showed complete loss of Smad4/DPC4 expression in cytoplasm (score, 0; 12.8%). Eighty-four and 31 cases were moderately and strongly positive, respectively (score, 2 and 3; 44.7% and 16.5%, respectively) and 49 cases were focally or weakly stained (score, 1; 29.1%). Immunohistochemistry analysis showed that the expression of Smad4/DPC4 was related to an increased risk of lymphatic invasion but not to other clinicopathological features of the tumors (tumor location, differentiation, growth pattern, T stage, direct invasion, vascular invasion, and nodal metastasis). There was no significant association between Smad4/DPC4 expression and patient survival. Conclusions: The present research is the first study to evaluate Smad4/DPC4 expression in a large sample of SACs with clinicopathologic correlation. Future studies should focus on the immunohistochemical and molecular characteristics of SACs to clarify their tumorigenesis.
참고문헌 (17)
- Chang HK, "Adenocarcinoma of the small intestine: a multi-institutional study of 197 surgically resected cases", Hum Pathol, 41, pp.1087~1096 (2010)
- Zouhairi ME, "Small bowel adenocarcinoma", Curr Treat Options Oncol, 9, pp.388~399 (2008)
- Svrcek M, "Immunohistochemical analysis of adenocarcinoma of the small intestine: a tissue microarray study", J Clin Pathol, 56, pp.898~903 (2003)
- Wheeler JM, "An insight into the genetic pathway of adenocarcinoma of the small intestine", Gut, 50, pp.218~223 (2002)
- Bläker H, "Genetics of adenocarcinomas of the small intestine: frequent deletions at chromosome 18q and mutations of the SMAD4 gene", Oncogene, 21, pp.158~164 (2002)
- Zhang MQ, "Immunohistochemical investigation of tumorigenic pathways in small intestinal adenocarcinoma: a comparison with colorectal adenocarcinoma", Mod Pathol, 19, pp.573~580 (2006)
- Hahn SA, "DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1", Science, 271, pp.350~353 (1996)
- Miyaki M, "Role of Smad4 (DPC4) inactivation in human cancer", Biochem Biophys Res Commun, 306, pp.799~804 (2003)
- McCarthy DM, "Role of the DPC4 tumor suppressor gene in adenocarcinoma of the ampulla of Vater: analysis of 140 cases", Mod Pathol, 16, pp.272~278 (2003)
- Maitra A, "Loss of Dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease", Am J Pathol, 157, pp.1105~1111 (2000)
- Wang LH, "Inactivation of SMAD4 tumor suppressor gene during gastric carcinoma progression", Clin Cancer Res, 13, pp.102~110 (2007)
- Hua Z, "Loss of DPC4 expression and its correlation with clinicopathological parameters in pancreatic carcinoma", World J Gastroenterol, 9, pp.2764~2767 (2003)
- Delpu Y, "Genetic and epigenetic alterations in pancreatic carcinogenesis", Curr Genomics, 12, pp.15~24 (2011)
- Wilentz RE, "Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas: a new marker of DPC4 inactivation", Am J Pathol, 156, pp.37~43 (2000)
- Peng B, "Suppression of tumorigenesis and induction of p15(ink4b) by Smad4", DPC4 in human pancreatic cancer cells, 2002, pp.8, 3628~3638
- Sclabas GM, "Frequency of subtypes of biliary intraductal papillary mucinous neoplasm and their MUC1, MUC2, and DPC4 expression patterns differ from pancreatic intraductal papillary mucinous neoplasm", J Am Coll Surg, 214, pp.27~32 (2012)
- Sheehan GM, "Smad4 protein expression correlates with grade, stage, and DNA ploidy in prostatic adenocarcinomas", Hum Pathol, 36, pp.1204~1209 (2005)